Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study.

about

Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?

P2860

Q58724084-CDA3515E-6A9F-4F73-B7CB-F3536786B02D

P2860

Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study.

Item

http://www.wikidata.org/entity/Q42293363

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Minimal disease activity and i ...... s-sectional multicenter study.

@en

Minimal disease activity and i ...... s-sectional multicenter study.

@nl

type

Item

label

Minimal disease activity and i ...... s-sectional multicenter study.

@en

Minimal disease activity and i ...... s-sectional multicenter study.

@nl

prefLabel

Minimal disease activity and i ...... s-sectional multicenter study.

@en

Minimal disease activity and i ...... s-sectional multicenter study.

@nl

P1476

Minimal disease activity and i ...... s-sectional multicenter study.

@en

P2093

Ana Cábez

http://www.w3.org/2001/XMLSchema#string

Carlos Montilla

http://www.w3.org/2001/XMLSchema#string

MAAPS study group

http://www.w3.org/2001/XMLSchema#string

María Montoro

http://www.w3.org/2001/XMLSchema#string

Miguel Abad

http://www.w3.org/2001/XMLSchema#string

Susana Gómez

http://www.w3.org/2001/XMLSchema#string

P2860

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data.

Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies.

Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis.

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.

Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype.

Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment.

Defining remission in psoriatic arthritis.

The Psoriatic Arthritis Impact of Disease 12-item questionnaire: equivalence, reliability, validity, and feasibility of the touch-screen administration versus the paper-and-pencil version.

P2888

s13075-017-1277-1

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13075-017-1277-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Juan D Cañete

Rubén Queiró

P577

2017-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084252290

http://www.w3.org/2001/XMLSchema#string

P698

28356155

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

5372277

http://www.w3.org/2001/XMLSchema#string

Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study.

about

P2860

P2860

Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932